The Patent Finder

Terms ending in 2034

Kymab Limited

Every in-force patent on Kymab Limited's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,783,618Manipulation of Immunoglobulin Gene Diversity and Multi-Antibody Therapeutics
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 11,707,056Animals, Repertoires & Methods
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 8,945,560Method of Treating Rheumatoid Arthritis Using Antibody to IL6R
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 8,980,273Method of Treating Atopic Dermatitis or Asthma Using Antibody to IL4RA
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 8,986,691Method of Treating Atopic Dermatitis or Asthma Using Antibody to IL4RA
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 8,986,694Targeting Human NAV1.7 Variants for Treatment of Pain
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 8,992,927Targeting Human NAV1.7 Variants for Treatment of Pain
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,017,678Method of Treating Rheumatoid Arthritis Using Antibody to IL6R
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,023,359Targeting Rare Human PCSK9 Variants for Cholesterol Treatment
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,045,545Precision Medicine by Targeting PD-L1 Variants for Treatment of Cancer
In force
 · Medium confidence
Kymab LimitedIn forceMedium confidence
19 more term ends in 2034 · Pro
10 of 29 patents shown. Soonest term end first, then patent number.
Pro members see all 29.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited